Tower Research Capital (TRC)’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.15K | Sell |
|
|||||
|
2024
Q4 | $44.4K | Sell |
|
|||||
|
2024
Q3 | $25.2K | Buy |
|
|||||
|
2024
Q2 | $22.1K | Buy |
|
|||||
|
2024
Q1 | $6.53K | Sell |
|
|||||
|
2023
Q4 | $10.2K | Buy |
|
|||||
|
2023
Q3 | $29.2K | Buy |
|
|||||
|
2023
Q2 | $12.5K | Sell |
|
|||||
|
2023
Q1 | $17K | Buy |
|
|||||
|
2022
Q4 | $10K | Sell |
|
|||||
|
2022
Q3 | $125K | Sell |
|
|||||
|
2022
Q2 | $184K | Buy |
|
|||||
|
2022
Q1 | $22K | Sell |
|
|||||
|
2021
Q4 | $22K | Sell |
|
|||||
|
2021
Q3 | $120K | Sell |
|
|||||
|
2021
Q2 | $149K | Buy |
|
|||||
|
2021
Q1 | $17K | Buy |
|
|||||
|
2020
Q4 | $2K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $0 | Sell |
|
|||||
|
2019
Q3 | $7K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $6K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $7K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1K | Buy |
|
|||||
|
2017
Q3 | $1K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $3K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $4K | Sell |
|
|||||
|
2015
Q4 | $22K | Buy |
|